Please login to the form below

Not currently logged in
Email:
Password:

Amylyx

This page shows the latest Amylyx news and features for those working in and with pharma, biotech and healthcare.

Amylyx’s Relyvrio receives FDA approval for ALS treatment

Amylyx’s Relyvrio receives FDA approval for ALS treatment

Joshua Cohen and Justin Klee, co-chief executive officers of Amylyx said the approval was “an exciting milestone for the ALS community”. ... The European Medicines Agency is reviewing the company’s marketing authorisation application for Relyvrio

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals

    The founder and former chief executive officer of Biogen Dr Walter Gilbert has been elected to Amylyx Pharmaceuticals' board of directors. ... Justin Klee, co-founder and president of Amylyx, said: “Dr Gilbert brings an enormous breadth of experience

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Evoke Mind+Matter Evoke Mind+Matter

    They include: Aerogen, Akcea, Allakos, Alexion, Amylyx Pharmaceuticals, Astellas, Baxter Healthcare, Bayer, Biocryst, Biogen, Biomarin, Bio-Oil, Boehringer Ingelheim, Cryoport, Colgate Palmolive, CSL Behring, Eiger BioPharmaceuticals, EIT Health,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...